JAYPIRCA
NDC 0002-7026, pirtobrutinib, tablet, coated, from Eli Lilly and Company.
- Product NDC
- 0002-7026
- Status
- Listed
- Labeler
- Eli Lilly and Company
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216059
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0002-7026 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PIRTOBRUTINIB100 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Bruton's Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Kinase Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0002-7026-60 | 00002702660 | 60 TABLET, COATED in 1 BOTTLE (0002-7026-60) |
| 0002-7026-99 | 00002702699 | 30 TABLET, COATED in 1 BOTTLE (0002-7026-99) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bd551845-0878-49a4-860f-839b83f6b801
Use it
Look up 0002-7026 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0002-7026 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0002-7026. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.